REGULATORY COMPLIANCE – Page 32

Electronic signatures misused during validation lifecycle – 21 CFR Part 11 compliance gaps

Identifying the early signs of electronic signature misuse is pivotal for timely interventions. Symptoms may manifest in various areas:Click to read the full article.

Archival process non-compliant during routine studies – CAPA for GLP system gaps

Identifying symptoms of archival process non-compliance is crucial for timely intervention. Key symptoms may include:Click to read the full article.

CSV compliance weak during lifecycle management – preventing repeat validation findings

Strengthening CSV Compliance Throughout the Lifecycle to Prevent Validation Issues As pharmaceutical organizations strive to maintain GMP compliance, they often face challenges related to Computerized System Validation (CSV). Regular deficiencies…

Hybrid paper-electronic workflows uncontrolled during compliance audit – CAPA and revalidation strategy

Identifying symptoms indicative of issues within hybrid workflows is crucial for timely resolution. Common signals include:Click to read the full article.

Inadequate worst-case selection during inspection readiness – regulatory deficiency risk

Recognizing the early signs of inadequate worst-case selection is crucial for an effective response. Some of the common symptoms on the production floor or in the labs include:Click to read…

Record retention failures during validation lifecycle – preventing repeat Part 11 findings

Identifying symptoms associated with record retention failures early can mitigate further complications. Here are some common indicators:Click to read the full article.

Change impact not assessed during system upgrades – CAPA and revalidation strategy

Recognizing early warning signs of change impacts during system upgrades is crucial for maintaining compliance. Here are common symptoms to be aware of:Click to read the full article.

Record retention failures during system upgrade – preventing repeat Part 11 findings

Recognizing early symptoms of record retention failures is crucial. These can manifest in various forms that may include:Click to read the full article.

Archival process non-compliant during study reconstruction – CAPA for GLP system gaps

Detecting signs of non-compliance starts with understanding what to look for on the production floor or in the laboratory environment. Common symptoms that may indicate issues with the archival process…

CSV compliance weak during change control – risk-based validation alignment

Enhancing CSV Compliance During Change Control for Effective Risk-Based Validation In the fast-paced world of pharmaceutical manufacturing, maintaining compliance with Computer System Validation (CSV) during change control processes presents a…

Electronic signatures misused during compliance audit – risk-based ERES remediation

Identifying symptoms of electronic signature misuse ensures proactive engagement before issues escalate into major compliance risks. Key indicators include:Click to read the full article.

Requalification overdue during change control – CAPA and revalidation strategy

Identifying symptoms early can prevent larger issues down the line. Common signals indicating issues related to overdue requalification during change control include:Click to read the full article.